Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Coalition for Epidemic Preparedness Innovations (CEPI) is an innovative global partnership between public, private, philanthropic, and civil organizations launched in 2017 to develop vaccines against future epidemics. CEPI focuses on accelerating the development of vaccines and other biologic countermeasures against epidemic and pandemic threats, including 'Disease X'. The organization provides funding and strategic coordination to biotech and pharma partners to ensure equitable access to vaccines during health crises. Its primary goal is to compress vaccine development timelines to 100 days to effectively contain outbreaks before they become global pandemics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Development for Preparedness.